Adlai Nortye (NASDAQ:ANL) Trading Up 3.9% – Time to Buy?

10 Sep 2026, 17:01 by Danessa Lincoln · The Markets Daily

Shares of Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL – Get Free Report) shot up 3.9% during mid-day trading on Thursday . The company traded as high as $15.56 and last traded at $15.26. Approximately 11,246 shares changed hands during mid-day trading, a decline of 97% from the average daily volume of 383,925 shares. The stock had previously closed at $14.69.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on ANL. HC Wainwright restated a “buy” rating and set a $20.00 price target on shares of Adlai Nortye in a report on Tuesday. Loop Capital set a $49.00 price objective on Adlai Nortye in a report on Tuesday. Cantor Fitzgerald started coverage on Adlai Nortye in a research report on Monday, June 22nd. They set an “overweight” rating for the company. Oppenheimer began coverage on Adlai Nortye in a research note on Thursday, May 28th. They issued an “outperform” rating and a $32.00 target price on the stock. Finally, Wall Street Zen raised Adlai Nortye from a “hold” rating to a “buy” rating in a research report on Saturday, August 22nd. Six analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $29.50.

Read Our Latest Stock Report on Adlai Nortye

Adlai Nortye Stock Up 4.6%

The company has a debt-to-equity ratio of 0.04, a current ratio of 9.55 and a quick ratio of 0.65. The stock’s 50 day simple moving average is $12.78 and its 200-day simple moving average is $11.50.

Insider Activity

In related news, CFO Xiaofeng Ye sold 5,667 shares of the company’s stock in a transaction on Wednesday, August 26th. The shares were sold at an average price of $14.25, for a total value of $80,754.75. Following the completion of the sale, the chief financial officer directly owned 147,757 shares in the company, valued at approximately $2,105,537.25. This represents a 3.69% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Hedge Funds Weigh In On Adlai Nortye

Several institutional investors have recently bought and sold shares of the stock. SmartHarvest Portfolios LLC lifted its position in shares of Adlai Nortye by 8.5% in the first quarter. SmartHarvest Portfolios LLC now owns 16,367 shares of the company’s stock worth $113,000 after buying an additional 1,279 shares during the last quarter. Renaissance Technologies LLC acquired a new position in shares of Adlai Nortye during the 1st quarter valued at about $457,000. ADAR1 Capital Management LLC bought a new position in shares of Adlai Nortye in the 1st quarter valued at approximately $816,000. Affinity Asset Advisors LLC bought a new position in shares of Adlai Nortye in the 1st quarter valued at approximately $1,140,000. Finally, Seven Fleet Capital Management LP acquired a new stake in Adlai Nortye in the 2nd quarter worth approximately $1,302,000. 35.21% of the stock is currently owned by institutional investors.

About Adlai Nortye

(Get Free Report)

Adlai Nortye Inc (NASDAQ: ANL) is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.

Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.